Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Ankylosing Spondylitis Treatment Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Ankylosing Spondylitis Treatment Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Ankylosing Spondylitis Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ankylosing Spondylitis Treatment Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Ankylosing Spondylitis Treatment Drug total market, 2019-2030, (USD Million)
Global Ankylosing Spondylitis Treatment Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Ankylosing Spondylitis Treatment Drug total market, key domestic companies and share, (USD Million)
Global Ankylosing Spondylitis Treatment Drug revenue by player and market share 2019-2024, (USD Million)
Global Ankylosing Spondylitis Treatment Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Ankylosing Spondylitis Treatment Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Ankylosing Spondylitis Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Merck, Eisai, Novartis, Pfizer, Johson & Johson, Abbive, UCB and Amgen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ankylosing Spondylitis Treatment Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Ankylosing Spondylitis Treatment Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Ankylosing Spondylitis Treatment Drug Market, Segmentation by Type
    Non-steroidal Anti-inflammatory Drugs
    Inhibitor

Global Ankylosing Spondylitis Treatment Drug Market, Segmentation by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
    Other

Companies Profiled:
    Abbott
    Merck
    Eisai
    Novartis
    Pfizer
    Johson & Johson
    Abbive
    UCB
    Amgen
    Takeda
    Mitsubishi Tanabe
    Hisun Pharm
    Guojian Pharmaceutical
    Bio-Thera Solutions
    Maibo Pharma
    Celgen Pharm

Key Questions Answered
1. How big is the global Ankylosing Spondylitis Treatment Drug market?
2. What is the demand of the global Ankylosing Spondylitis Treatment Drug market?
3. What is the year over year growth of the global Ankylosing Spondylitis Treatment Drug market?
4. What is the total value of the global Ankylosing Spondylitis Treatment Drug market?
5. Who are the major players in the global Ankylosing Spondylitis Treatment Drug market?

Table of Contents

1 Supply Summary
    1.1 Ankylosing Spondylitis Treatment Drug Introduction
    1.2 World Ankylosing Spondylitis Treatment Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Ankylosing Spondylitis Treatment Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Ankylosing Spondylitis Treatment Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.3 China Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.4 Europe Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.5 Japan Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.6 South Korea Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.7 ASEAN Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
        1.3.8 India Ankylosing Spondylitis Treatment Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Ankylosing Spondylitis Treatment Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Ankylosing Spondylitis Treatment Drug Major Market Trends

2 Demand Summary
    2.1 World Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.2 World Ankylosing Spondylitis Treatment Drug Consumption Value by Region
        2.2.1 World Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2019-2024)
        2.2.2 World Ankylosing Spondylitis Treatment Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.4 China Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.5 Europe Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.6 Japan Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.7 South Korea Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.8 ASEAN Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)
    2.9 India Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030)

3 World Ankylosing Spondylitis Treatment Drug Companies Competitive Analysis
    3.1 World Ankylosing Spondylitis Treatment Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Ankylosing Spondylitis Treatment Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Ankylosing Spondylitis Treatment Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Ankylosing Spondylitis Treatment Drug in 2023
    3.3 Ankylosing Spondylitis Treatment Drug Company Evaluation Quadrant
    3.4 Ankylosing Spondylitis Treatment Drug Market: Overall Company Footprint Analysis
        3.4.1 Ankylosing Spondylitis Treatment Drug Market: Region Footprint
        3.4.2 Ankylosing Spondylitis Treatment Drug Market: Company Product Type Footprint
        3.4.3 Ankylosing Spondylitis Treatment Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Ankylosing Spondylitis Treatment Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Ankylosing Spondylitis Treatment Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Ankylosing Spondylitis Treatment Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Ankylosing Spondylitis Treatment Drug Consumption Value Comparison
        4.2.1 United States VS China: Ankylosing Spondylitis Treatment Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Ankylosing Spondylitis Treatment Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Ankylosing Spondylitis Treatment Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Ankylosing Spondylitis Treatment Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024)
    4.4 China Based Companies Ankylosing Spondylitis Treatment Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Ankylosing Spondylitis Treatment Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024)
    4.5 Rest of World Based Ankylosing Spondylitis Treatment Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Ankylosing Spondylitis Treatment Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Ankylosing Spondylitis Treatment Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Non-steroidal Anti-inflammatory Drugs
        5.2.2 Inhibitor
    5.3 Market Segment by Type
        5.3.1 World Ankylosing Spondylitis Treatment Drug Market Size by Type (2019-2024)
        5.3.2 World Ankylosing Spondylitis Treatment Drug Market Size by Type (2025-2030)
        5.3.3 World Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Ankylosing Spondylitis Treatment Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacy
        6.2.2 Retail Pharmacy
        6.2.3 Online Pharmacy
        6.2.4 Other
        6.2.5 Other
    6.3 Market Segment by Application
        6.3.1 World Ankylosing Spondylitis Treatment Drug Market Size by Application (2019-2024)
        6.3.2 World Ankylosing Spondylitis Treatment Drug Market Size by Application (2025-2030)
        6.3.3 World Ankylosing Spondylitis Treatment Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Details
        7.1.2 Abbott Major Business
        7.1.3 Abbott Ankylosing Spondylitis Treatment Drug Product and Services
        7.1.4 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Abbott Recent Developments/Updates
        7.1.6 Abbott Competitive Strengths & Weaknesses
    7.2 Merck
        7.2.1 Merck Details
        7.2.2 Merck Major Business
        7.2.3 Merck Ankylosing Spondylitis Treatment Drug Product and Services
        7.2.4 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Merck Recent Developments/Updates
        7.2.6 Merck Competitive Strengths & Weaknesses
    7.3 Eisai
        7.3.1 Eisai Details
        7.3.2 Eisai Major Business
        7.3.3 Eisai Ankylosing Spondylitis Treatment Drug Product and Services
        7.3.4 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Eisai Recent Developments/Updates
        7.3.6 Eisai Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Ankylosing Spondylitis Treatment Drug Product and Services
        7.4.4 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Product and Services
        7.5.4 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Johson & Johson
        7.6.1 Johson & Johson Details
        7.6.2 Johson & Johson Major Business
        7.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Services
        7.6.4 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Johson & Johson Recent Developments/Updates
        7.6.6 Johson & Johson Competitive Strengths & Weaknesses
    7.7 Abbive
        7.7.1 Abbive Details
        7.7.2 Abbive Major Business
        7.7.3 Abbive Ankylosing Spondylitis Treatment Drug Product and Services
        7.7.4 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Abbive Recent Developments/Updates
        7.7.6 Abbive Competitive Strengths & Weaknesses
    7.8 UCB
        7.8.1 UCB Details
        7.8.2 UCB Major Business
        7.8.3 UCB Ankylosing Spondylitis Treatment Drug Product and Services
        7.8.4 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 UCB Recent Developments/Updates
        7.8.6 UCB Competitive Strengths & Weaknesses
    7.9 Amgen
        7.9.1 Amgen Details
        7.9.2 Amgen Major Business
        7.9.3 Amgen Ankylosing Spondylitis Treatment Drug Product and Services
        7.9.4 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Amgen Recent Developments/Updates
        7.9.6 Amgen Competitive Strengths & Weaknesses
    7.10 Takeda
        7.10.1 Takeda Details
        7.10.2 Takeda Major Business
        7.10.3 Takeda Ankylosing Spondylitis Treatment Drug Product and Services
        7.10.4 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Takeda Recent Developments/Updates
        7.10.6 Takeda Competitive Strengths & Weaknesses
    7.11 Mitsubishi Tanabe
        7.11.1 Mitsubishi Tanabe Details
        7.11.2 Mitsubishi Tanabe Major Business
        7.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Services
        7.11.4 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Mitsubishi Tanabe Recent Developments/Updates
        7.11.6 Mitsubishi Tanabe Competitive Strengths & Weaknesses
    7.12 Hisun Pharm
        7.12.1 Hisun Pharm Details
        7.12.2 Hisun Pharm Major Business
        7.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Services
        7.12.4 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Hisun Pharm Recent Developments/Updates
        7.12.6 Hisun Pharm Competitive Strengths & Weaknesses
    7.13 Guojian Pharmaceutical
        7.13.1 Guojian Pharmaceutical Details
        7.13.2 Guojian Pharmaceutical Major Business
        7.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Services
        7.13.4 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Guojian Pharmaceutical Recent Developments/Updates
        7.13.6 Guojian Pharmaceutical Competitive Strengths & Weaknesses
    7.14 Bio-Thera Solutions
        7.14.1 Bio-Thera Solutions Details
        7.14.2 Bio-Thera Solutions Major Business
        7.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Services
        7.14.4 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Bio-Thera Solutions Recent Developments/Updates
        7.14.6 Bio-Thera Solutions Competitive Strengths & Weaknesses
    7.15 Maibo Pharma
        7.15.1 Maibo Pharma Details
        7.15.2 Maibo Pharma Major Business
        7.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Services
        7.15.4 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Maibo Pharma Recent Developments/Updates
        7.15.6 Maibo Pharma Competitive Strengths & Weaknesses
    7.16 Celgen Pharm
        7.16.1 Celgen Pharm Details
        7.16.2 Celgen Pharm Major Business
        7.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Services
        7.16.4 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Celgen Pharm Recent Developments/Updates
        7.16.6 Celgen Pharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Ankylosing Spondylitis Treatment Drug Industry Chain
    8.2 Ankylosing Spondylitis Treatment Drug Upstream Analysis
    8.3 Ankylosing Spondylitis Treatment Drug Midstream Analysis
    8.4 Ankylosing Spondylitis Treatment Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Ankylosing Spondylitis Treatment Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Ankylosing Spondylitis Treatment Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Ankylosing Spondylitis Treatment Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Ankylosing Spondylitis Treatment Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Ankylosing Spondylitis Treatment Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Ankylosing Spondylitis Treatment Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Ankylosing Spondylitis Treatment Drug Players in 2023
    Table 12. World Ankylosing Spondylitis Treatment Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Ankylosing Spondylitis Treatment Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Ankylosing Spondylitis Treatment Drug Player
    Table 15. Ankylosing Spondylitis Treatment Drug Market: Company Product Type Footprint
    Table 16. Ankylosing Spondylitis Treatment Drug Market: Company Product Application Footprint
    Table 17. Ankylosing Spondylitis Treatment Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Ankylosing Spondylitis Treatment Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Ankylosing Spondylitis Treatment Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Ankylosing Spondylitis Treatment Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Ankylosing Spondylitis Treatment Drug Revenue Market Share (2019-2024)
    Table 23. China Based Ankylosing Spondylitis Treatment Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Ankylosing Spondylitis Treatment Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Ankylosing Spondylitis Treatment Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Ankylosing Spondylitis Treatment Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Ankylosing Spondylitis Treatment Drug Revenue Market Share (2019-2024)
    Table 29. World Ankylosing Spondylitis Treatment Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Ankylosing Spondylitis Treatment Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Ankylosing Spondylitis Treatment Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Ankylosing Spondylitis Treatment Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Ankylosing Spondylitis Treatment Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Ankylosing Spondylitis Treatment Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Abbott Basic Information, Area Served and Competitors
    Table 36. Abbott Major Business
    Table 37. Abbott Ankylosing Spondylitis Treatment Drug Product and Services
    Table 38. Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Abbott Recent Developments/Updates
    Table 40. Abbott Competitive Strengths & Weaknesses
    Table 41. Merck Basic Information, Area Served and Competitors
    Table 42. Merck Major Business
    Table 43. Merck Ankylosing Spondylitis Treatment Drug Product and Services
    Table 44. Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Merck Recent Developments/Updates
    Table 46. Merck Competitive Strengths & Weaknesses
    Table 47. Eisai Basic Information, Area Served and Competitors
    Table 48. Eisai Major Business
    Table 49. Eisai Ankylosing Spondylitis Treatment Drug Product and Services
    Table 50. Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Eisai Recent Developments/Updates
    Table 52. Eisai Competitive Strengths & Weaknesses
    Table 53. Novartis Basic Information, Area Served and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Ankylosing Spondylitis Treatment Drug Product and Services
    Table 56. Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Novartis Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer Ankylosing Spondylitis Treatment Drug Product and Services
    Table 62. Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Johson & Johson Basic Information, Area Served and Competitors
    Table 66. Johson & Johson Major Business
    Table 67. Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Services
    Table 68. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Johson & Johson Recent Developments/Updates
    Table 70. Johson & Johson Competitive Strengths & Weaknesses
    Table 71. Abbive Basic Information, Area Served and Competitors
    Table 72. Abbive Major Business
    Table 73. Abbive Ankylosing Spondylitis Treatment Drug Product and Services
    Table 74. Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Abbive Recent Developments/Updates
    Table 76. Abbive Competitive Strengths & Weaknesses
    Table 77. UCB Basic Information, Area Served and Competitors
    Table 78. UCB Major Business
    Table 79. UCB Ankylosing Spondylitis Treatment Drug Product and Services
    Table 80. UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. UCB Recent Developments/Updates
    Table 82. UCB Competitive Strengths & Weaknesses
    Table 83. Amgen Basic Information, Area Served and Competitors
    Table 84. Amgen Major Business
    Table 85. Amgen Ankylosing Spondylitis Treatment Drug Product and Services
    Table 86. Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Amgen Recent Developments/Updates
    Table 88. Amgen Competitive Strengths & Weaknesses
    Table 89. Takeda Basic Information, Area Served and Competitors
    Table 90. Takeda Major Business
    Table 91. Takeda Ankylosing Spondylitis Treatment Drug Product and Services
    Table 92. Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Takeda Recent Developments/Updates
    Table 94. Takeda Competitive Strengths & Weaknesses
    Table 95. Mitsubishi Tanabe Basic Information, Area Served and Competitors
    Table 96. Mitsubishi Tanabe Major Business
    Table 97. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Services
    Table 98. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Mitsubishi Tanabe Recent Developments/Updates
    Table 100. Mitsubishi Tanabe Competitive Strengths & Weaknesses
    Table 101. Hisun Pharm Basic Information, Area Served and Competitors
    Table 102. Hisun Pharm Major Business
    Table 103. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Services
    Table 104. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Hisun Pharm Recent Developments/Updates
    Table 106. Hisun Pharm Competitive Strengths & Weaknesses
    Table 107. Guojian Pharmaceutical Basic Information, Area Served and Competitors
    Table 108. Guojian Pharmaceutical Major Business
    Table 109. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Services
    Table 110. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Guojian Pharmaceutical Recent Developments/Updates
    Table 112. Guojian Pharmaceutical Competitive Strengths & Weaknesses
    Table 113. Bio-Thera Solutions Basic Information, Area Served and Competitors
    Table 114. Bio-Thera Solutions Major Business
    Table 115. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Services
    Table 116. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Bio-Thera Solutions Recent Developments/Updates
    Table 118. Bio-Thera Solutions Competitive Strengths & Weaknesses
    Table 119. Maibo Pharma Basic Information, Area Served and Competitors
    Table 120. Maibo Pharma Major Business
    Table 121. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Services
    Table 122. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Maibo Pharma Recent Developments/Updates
    Table 124. Celgen Pharm Basic Information, Area Served and Competitors
    Table 125. Celgen Pharm Major Business
    Table 126. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Services
    Table 127. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 128. Global Key Players of Ankylosing Spondylitis Treatment Drug Upstream (Raw Materials)
    Table 129. Ankylosing Spondylitis Treatment Drug Typical Customers
List of Figure
    Figure 1. Ankylosing Spondylitis Treatment Drug Picture
    Figure 2. World Ankylosing Spondylitis Treatment Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Ankylosing Spondylitis Treatment Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Ankylosing Spondylitis Treatment Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Ankylosing Spondylitis Treatment Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Ankylosing Spondylitis Treatment Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Ankylosing Spondylitis Treatment Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Ankylosing Spondylitis Treatment Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Ankylosing Spondylitis Treatment Drug Markets in 2023
    Figure 27. United States VS China: Ankylosing Spondylitis Treatment Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Ankylosing Spondylitis Treatment Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Ankylosing Spondylitis Treatment Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type in 2023
    Figure 31. Non-steroidal Anti-inflammatory Drugs
    Figure 32. Inhibitor
    Figure 33. World Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2019-2030)
    Figure 34. World Ankylosing Spondylitis Treatment Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2023
    Figure 36. Hospital Pharmacy
    Figure 37. Retail Pharmacy
    Figure 38. Online Pharmacy
    Figure 39. Other
    Figure 40. Ankylosing Spondylitis Treatment Drug Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Abbott
Merck
Eisai
Novartis
Pfizer
Johson & Johson
Abbive
UCB
Amgen
Takeda
Mitsubishi Tanabe
Hisun Pharm
Guojian Pharmaceutical
Bio-Thera Solutions
Maibo Pharma
Celgen Pharm